Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Equity Average (2016 - 2025)

Historic Equity Average for Cryo Cell International (CCEL) over the last 15 years, with Q3 2025 value amounting to -$15.2 million.

  • Cryo Cell International's Equity Average fell 4970.94% to -$15.2 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$15.2 million, marking a year-over-year decrease of 4970.94%. This contributed to the annual value of -$12.1 million for FY2024, which is 9312.0% down from last year.
  • According to the latest figures from Q3 2025, Cryo Cell International's Equity Average is -$15.2 million, which was down 4970.94% from -$15.1 million recorded in Q2 2025.
  • Cryo Cell International's Equity Average's 5-year high stood at $4.5 million during Q4 2021, with a 5-year trough of -$15.2 million in Q3 2025.
  • Over the past 5 years, Cryo Cell International's median Equity Average value was -$2.0 million (recorded in 2022), while the average stood at -$4.2 million.
  • Its Equity Average has fluctuated over the past 5 years, first skyrocketed by 29346.62% in 2022, then tumbled by 222124.09% in 2024.
  • Quarter analysis of 5 years shows Cryo Cell International's Equity Average stood at $4.5 million in 2021, then crashed by 143.52% to -$2.0 million in 2022, then tumbled by 182.55% to -$5.5 million in 2023, then tumbled by 106.16% to -$11.4 million in 2024, then plummeted by 33.44% to -$15.2 million in 2025.
  • Its last three reported values are -$15.2 million in Q3 2025, -$15.1 million for Q2 2025, and -$13.9 million during Q1 2025.